Results 171 to 180 of about 34,871 (236)

Beyond discovery: are we understanding PET tracers as fast as we invent them? a critical review. [PDF]

EJNMMI Res
Ibrahim EA.
europepmc   +1 more source

Radiotherapy meets anticancer metallodrugs. [PDF]

Med Rev (2021)
Zhang S, Shen S, Li J, Fu Q, Guo Z, Liu Z.   +5 more
europepmc   +1 more source

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]

EJNMMI Res
Klomp MJ, Erkens SE, van den Brink L, van Weerden WM, Dalm SU.   +4 more
europepmc   +1 more source

177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public. [PDF]

Nuklearmedizin
Schütze C, Borowski M, Freesmeyer M, Freudenberg R, Hänscheid H, Kurth J, Linde MR, Militzer LC, Sattler B, Schmidt TN, Soubiran P, Steffner M, Stegger L, Wanke C, Kühnel C.   +14 more
europepmc   +1 more source

Pathways and challenges in the clinical translational of radiopharmaceuticals for pediatric investigations. [PDF]

Front Med (Lausanne)
Stauff E, Karimi H, Kecskemethy HH, Shaffer TH, Vali R, Averill LW, Yue X.   +6 more
europepmc   +1 more source

177 Lu-FAP-2286 Combined Chemotherapy in a Case of Thymus Nonkeratinizing Squamous Carcinoma With Superior Vena Cava Syndrome. [PDF]

Clin Nucl Med
Deng J, Wang Y, Xu T, Chen Y.
europepmc   +1 more source

Process-Related Incidents in Nuclear Medicine: A Four-Year Single-Center Retrospective Analysis to Support the Implementation of a Scenario-Based Radiopharmacy Training. [PDF]

Pharmacy (Basel)
Soualy Y, Renaud SC, Torchio J, Fouillet J, Ensenat J, Rubira L, Fersing C.   +6 more
europepmc   +1 more source

Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831. [PDF]

Pharmaceuticals (Basel)
Iacovitti CM, Marin A, Tasevski S, Martinello C, Cuzzocrea M, Paone G, Rizzo A, Albano D, Treglia G.   +8 more
europepmc   +1 more source

Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals. [PDF]

Molecules
Napolitano R, Speltri G, Martini P, Porto F, Marvelli L, Niorettini A, Uccelli L, Urso L, Filippi L, Uslu H, Canitez B, Kösem HA, Boschi A.   +12 more
europepmc   +1 more source

Feasibility of albumin binding modulation in FAP-targeting radiopharmaceuticals: insights from molecular docking and experimental analysis. [PDF]

EJNMMI Radiopharm Chem
Shokrollahi S, Amiri A.
europepmc   +1 more source